AltMountain

Bioverge Funds, Excision Bio I, LLC

Boise, ID · CIK 1806781
Status: no Form D since Mar 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Bioverge Funds, Excision Bio I, LLC is a private investment fund based in Boise, Idaho. According to its most recent Form D, filed Mar 16, 2020, it has sold $142,200 of interests to 14 investors since its first sale in Mar 2020. The minimum investment it accepts from an outside investor is $5,000. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Neil Bioverge Funds Management, LLC Littman.

Total raised
$142,200Cumulative sales reported on Form D
Investors
14
First sale
Mar 12, 2020
Minimum investment
$5,000
Who can invest
Not stated
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Neil Bioverge Funds Management, LLC Littman
Latest Form D
Mar 16, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Questions about Bioverge Funds, Excision Bio I, LLC

What is the minimum investment for Bioverge Funds, Excision Bio I, LLC?

According to its latest Form D, filed Mar 16, 2020, the minimum investment Bioverge Funds, Excision Bio I, LLC accepts from an outside investor is $5,000.

Who can invest in Bioverge Funds, Excision Bio I, LLC?

Bioverge Funds, Excision Bio I, LLC is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.

How much has Bioverge Funds, Excision Bio I, LLC raised?

Bioverge Funds, Excision Bio I, LLC reports $142,200 sold from 14 investors on its Form D filed Mar 16, 2020. This is cumulative sales since the offering began, not current assets or performance.

Where is Bioverge Funds, Excision Bio I, LLC based?

Bioverge Funds, Excision Bio I, LLC is based in Boise, Idaho.

When did Bioverge Funds, Excision Bio I, LLC launch?

Bioverge Funds, Excision Bio I, LLC reports its first sale in Mar 2020.

Size compared with every private investment fund

Raised more than 18% of the 17 private investment funds based in Idaho, and more than 3% of all 10,363 that report sales.

More private investment funds in Boise

Similar-size private investment funds in Idaho

All private investment funds in Idaho